title: Galantamine for Alzheimer's disease and mild cognitive impairment.
authors.forename: Cristina
authors.initials: C
authors.lastname: Cusi
authors.forename: Teresa Anna
authors.initials: TA
authors.lastname: Cantisani
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Celani
authors.forename: Barbara
authors.initials: B
authors.lastname: Incorvaia
authors.forename: Enrico
authors.initials: E
authors.lastname: Righetti
authors.forename: Livia
authors.initials: L
authors.lastname: Candelise
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D003072:Cognition Disorders / Q000188:drug therapy* / Q000523:psychology; D003692:Delayed-Action Preparations; D005702:Galantamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D003692:Delayed-Action Preparations; D018697:Nootropic Agents; D005702:Galantamine